InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: rod5247 post# 4031

Saturday, 07/25/2015 4:41:00 PM

Saturday, July 25, 2015 4:41:00 PM

Post# of 8553
Halo changed how they account for upfront license fees, I stand corrected.

"Fourth Quarter and Full Year 2014 Financial Highlights
Revenues for the fourth quarter of 2014 were $30.4 million, compared to $12.5 million for the fourth quarter of 2013. Revenues in the fourth quarter included $5.9 million in product sales of bulk rHuPH20 for use in manufacturing Roche's collaboration products, $4.1 million in Hylenex® recombinant (hyaluronidase human injection) product sales, $4.0 million in royalty revenue from sales of products under our collaborations and a $15 million licensing fee from Janssen. Revenues for the full year were $75.3 million compared to $54.8 million in the previous year."

I remember Mr. Ramsay saying they had a choice and chose to amortize. I am sure I noticed the change for Q4 but the original method stuck in my feeble mind.

If this 23 million is handled the same, Halo will be green for Q2 and very possible for 1st half.

Very sorry for outdated/inaccurate information.

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News